N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2) (Middle Region) Peptid
Kurzübersicht für N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2) (Middle Region) Peptid (ABIN8106062)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- NAT2 Peptide - middle region
-
Sequenz
- TYRKFNYKDN TDLVEFKTLT EEEVEEVLRN IFKISLGRNL VPKPGDGSLT
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-NAT2 Antibody(ARP44197_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- NAT2 (N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2))
-
Hintergrund
-
Background Information: NAT2 is a N-acetyltransferase 2 (arylamine N-acetyltransferase 2). This enzyme functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in its gene are reponsible for the N-acetylation polymorphism in which human populations segregate into rapid,intermediate, and slow acetylator phenotypes. Polymorphisms in NAT2 are also associated with higher incidences of cancer and drug toxicity.
Alternative Symbols: AAC2, PNAT
-
Molekulargewicht
- 33kDa
-
Gen-ID
- 10
-
NCBI Accession
- NP_000006
-
UniProt
- P11245
Target
-
